Excimer laser alternative for psoriasis:
This article was originally published in Clinica
Laser Photonics subsidiary Acculase has applied for 510(k) marketing clearance in the US for its excimer laser to treat skin diseases such as psoriasis. It claims that the laser method will result in shorter treatment courses with fewer sessions than the currently used ultra-violet phototherapy, while avoiding exposure of the patient's whole body to ultraviolet light. Psoriasis affects 2% of the world's population and treatment costs are $5 billion in the US alone, said Carlsbad, California-based Laser Photonics.